Neuronetics (STIM) Tops Q2 EPS by 18c

Neuronetics (NASDAQ: STIM) reported Q2 EPS of ($0.17), $0.18 better than the analyst estimate of ($0.35). Revenue for the quarter came in at $17.6 million versus the consensus estimate of $17.36 million.

For earnings history and earnings-related data on Neuronetics (STIM) click here.

You May Also Be Interested In

• UBS sees a negative catalyst ahead for Nike: Here’s what to watch
• Astrana Health (ASTH) Mentioned as short at Glass House
• Lennar Corp. (LEN) Misses Q3 EPS by 10c